Vaccine

Details for Australian Patent Application No. 2008207025 (hide)

Owner GlaxoSmithKline Biologicals SA

Inventors Martin, Denis; Blais, Normand; Palmantier, Remi M.

Agent Shelston IP

Pub. Number AU-B-2008207025

PCT Pub. Number WO2008/087102

Priority 0700760.2 15.01.07 GB; 0701262.8 23.01.07 GB

Filing date 11 January 2008

Wipo publication date 24 July 2008

Acceptance publication date 23 August 2012

International Classifications

C07K 14/285 Peptides having more than 20 amino acids

A61K 39/00 Medicinal preparations containing antigens or antibodies

C07K 14/47 Peptides having more than 20 amino acids

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/087102 Priority application(s): WO2008/087102

23 August 2012 Application Accepted

  Published as AU-B-2008207025

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008207041-Ocular sensor for the detection of an analyte in eye water

2008207022-Capsule, means for piercing the base of a capsule and device for preparing a beverage